Involvement of monocyte/macrophage NLRP3-IL-1β signaling in the pathogenesis of myasthenia gravis.

Saved in:
Bibliographic Details
Title: Involvement of monocyte/macrophage NLRP3-IL-1β signaling in the pathogenesis of myasthenia gravis.
Authors: Zhou Y; Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, People's Republic of China; Shandong Institute of Neuroimmunology, Jinan, People's Republic of China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, People's Republic of China., Jia YF; Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, People's Republic of China., Du T; Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, People's Republic of China; Shandong Institute of Neuroimmunology, Jinan, People's Republic of China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, People's Republic of China., Zhang P; Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, People's Republic of China; Shandong Institute of Neuroimmunology, Jinan, People's Republic of China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, People's Republic of China., Yang XY; Jining Medical University, Jining, People's Republic of China., Zhai YY; Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, People's Republic of China., Li XL; Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, People's Republic of China; Shandong Institute of Neuroimmunology, Jinan, People's Republic of China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, People's Republic of China., Yang B; Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, People's Republic of China; Shandong Institute of Neuroimmunology, Jinan, People's Republic of China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, People's Republic of China., Liu RT; Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, People's Republic of China., Yang CL; Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, People's Republic of China; Shandong Institute of Neuroimmunology, Jinan, People's Republic of China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, People's Republic of China. Electronic address: muyilin1991@163.com., Duan RS; Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, People's Republic of China; Shandong Institute of Neuroimmunology, Jinan, People's Republic of China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, People's Republic of China. Electronic address: ruisheng_duan@163.com., Wang CC; Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, People's Republic of China; Shandong Institute of Neuroimmunology, Jinan, People's Republic of China; Shandong Provincial Medicine and Health Key Laboratory of Neuroimmunology, People's Republic of China. Electronic address: skyfly_32633@126.com.
Source: International immunopharmacology [Int Immunopharmacol] 2026 Jun 10; Vol. 185, pp. 116971. Date of Electronic Publication: 2026 Jun 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-1705
DOI:10.1016/j.intimp.2026.116971